|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Void growth simulations in single crystals显示文摘 | O'Regan T L Quinn D F Howe M A MeHugh P E | 1997 | Computational Mechanies1997，20，： | 1 |
| 2 | Randomized phase Ⅲ trial of high-dose interleukin-2 versus subcutaneous interleukin-2 and interferon in patients with metastatic renal cell carcinoma显示文摘 | McDermott D F Regan M Clark J I | 2005 | J Clini Oncol2005，23，1： | 1 |
| 3 | Cervical disc replacement in patients with and without previous adjacent level fusion surgery:a prospective study显示文摘 | Phillips F M Allen T R Regan J J | 2009 | Spine (Phila Pa 1976)2009，34，6： | 1 |
| 4 | A school out- break of Norwalk-like virus: evidence for airborne trans- mission显示文摘 | Marks P J Vipond I B Regan F M | 2003 | Epidemiol Infect2003，131，1： | 1 |
| 5 | Grain boundary mapping in polycrystalline graphene显示文摘 | KIM K LEE Z REGAN W KISIELOWSKI C CROMMIE M F ZETTL A | 2011 | ACS Nano2011，5，3： | 1 |
| 6 | Void growth simulations in single crystals显示文摘 | O'Regan T L Quinn D F Howe M A McHugh P E | 1997 | Computational Mechanics1997，20，： | 1 |
| 7 | Cervical disc replace- ment in patients with and without previous adjacent level fusion sur- gery: a prospective study显示文摘 | Phillips F M All:n T R Regan J J | 2009 | Spine2009，34，6： | 1 |
| 8 | Phase Ⅲ,randomized,double-blind,placebo-controlled multicenter trial of daily everolimus plus weekly trastuzumab and vinorelbine in trastuzumab-resistant,advanced breast cancer (BOLERO-3)显示文摘 | O' Regan R Ozguroglu M Andre F Toi M Jerusalem G Wilks S Isaacs C Xu B Masuda N Arena FP Yardley D Yap YS Mukhopadhyay P Douma S El-Hashimy M Taran T Sahmoud T Lebwohl D Gianni L | | 0，，15： | 1 |
| 9 | Everolimus for women with trastuzumab-resistant,HER2-positive,ad- vanced breast cancer (BOLERO-3) :a randomised,dou- ble-blind,placebo-controlled phase 3 trial 显示文摘 | Andre F O'Regan R Ozguroglu M | 2014 | Lancet On- col2014，15，6： | 1 |
| 10 | Acute ureteric calculus obstruction:unenhanced spiral CT versus HASTE MR urography and abdominal radiograph显示文摘 | REGAN F KUSZYK B BOHLMAN M E | 2005 | Br J Radiol2005，78，： | 1 |
| 11 | Ran- domized phase III trial of high-dose interleukin-2 versus subcutaneous interleukin-2 and interferon in patients with metastatic renal cell carcinoma显示文摘 | McDermott D F Regan M M Clark J I | 2005 | J Clin ()ncol2005，23，1： | 1 |
| 12 | Cloning of apoptosis-related genes by rcpresentational difference analysis of cNDA显示文摘 | Hubank M P rynlesson F Regan J | 2004 | Meth Mol Biol2004，282，： | 1 |
| 13 | Sevoflurane : a new inhalational anesthetic agent 显示文摘 | WALLIN R F REGAN B M NAPOLI M D | 1975 | Anesthesia & Analgesia1975，54，6： | 1 |
| 14 | Phase Ⅲ, randomized, double-blind, placebo-controlled muhicenter trial of daily everolimus plus weekly trastuzumab and vinorelbine in trastuzumab-resistant, advanced breast cancer (BOLERO-3) 显示文摘 | O'Regan R Ozguroglu M Andre F | 2013 | J Clin Oncol2013，31，15： | 1 |
| 15 | Phase I study of everolimus plus weekly paclitaxel and trastuzumab in pa- tients with metastatic breast cancer pretreated with trastu- zumab 显示文摘 | Andre F Campone M O'Regan R | 2010 | J of Clin Oncol2010，28，34： | 1 |
| 16 | Sevoflurane:a new inhalational anesthetic agent显示文摘 | Regan B M Napoli M D | 1975 | Anesth Analg1975，45，： | 1 |
| 17 | Everolimus for women with trastuzumab-resistant, HER2-positive, advanced breast cancer (BOLERO-3): a randomised, double-blind, place- bo-controlled phase 3 trial 显示文摘 | Andre F O'Regan R Ozguroglu M | 2014 | Lancet 0ncol2014，15，6： | 1 |
| 18 | Fracture toughness and impact behaviour of glass-fibre-reinforced polyamide 6,6 injection mouldings 显示文摘 | Akay M O'Regan D F Bailey R S | 1995 | Composites Science and Technology1995，55，2： | 1 |
| 19 | p27 and Skp2 immunoreaetivity and its clinical significance with endocrine and chemo-endocrine treatments in node-negative early breast cancer显示文摘 | RAVAIOLI A MONTI F REGAN M M | 2008 | Ann Oncol2008，19，4： | 1 |
| 20 | A sample extraction method for faster, more sensitive PCR-based detection of pathogens in blood culture 显示文摘 | REGAN J F FURTADO M R BREVNOV M G | 2012 | J Mol Diagn2012，14，2： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员